Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ashton

Showing results (121-130 of 248) with videos related to

Pageof 25
Sort By:
Scientific Reports|October 26, 2017
ALK and IGF-1R as independent targets in crizotinib resistant lung cancerChristabel Wilson, Mhairi Nimick, Hayley Nehoff, et al.
Pharmacology|August 30, 2007
The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memoryJohn C Ashton, Paul F Smith, Cynthia L Darlington
The Australian and New Zealand Journal of Surgery|June 1, 1988
A direct patient approach for pre-operative autologous blood donation and transfusionD J Roxby, R Seshadri, C Ashton, et al.
Occupational Therapy in Health Care|August 13, 2013
A pilot study: attitudes toward leisure and leisure motivation in adults with spinal cord injuryS E Wickham, C S Hanson, O Shechtman, et al.
Family Practice|December 1, 1994
The effect of patients' attendance rate on the consultation in a health centre in Saudi ArabiaE A al-Faris, M A al-Dayel, C Ashton
Journal of Animal Science|March 1, 1976
Relation of high temperature regimes to energy metabolism, body composition and feed and water intake in ratsW S Alhassan, J G Buchanan-Smith, G C Ashton
Neuroscience Letters|April 12, 2014
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in ratsJ R Rivers-Auty, P F Smith, J C Ashton
Neuroreport|December 21, 2011
Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemiaJack R Rivers, Simran D S Maggo, John C Ashton
CNS & Neurological Disorders Drug Targets|January 19, 2022
The Current Evidence for the Therapeutic Role of Curcumin in Alzheimer's DiseaseAbigail R Bland, John C Ashton, Mohammad Amjad Kamal, et al.
Cerebellum (London, England)|February 3, 2005
Immunohistochemical localization of cannabinoid CB1 receptor in inhibitory interneurons in the cerebellumJohn C Ashton, Ian Appleton, Cynthia L Darlington, et al.
Pageof 25

Showing results (121-130 of 248) with videos related to

Sort By:
Pageof 25
Scientific Reports|October 26, 2017
ALK and IGF-1R as independent targets in crizotinib resistant lung cancerChristabel Wilson, Mhairi Nimick, Hayley Nehoff, et al.
Pharmacology|August 30, 2007
The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memoryJohn C Ashton, Paul F Smith, Cynthia L Darlington
The Australian and New Zealand Journal of Surgery|June 1, 1988
A direct patient approach for pre-operative autologous blood donation and transfusionD J Roxby, R Seshadri, C Ashton, et al.
Occupational Therapy in Health Care|August 13, 2013
A pilot study: attitudes toward leisure and leisure motivation in adults with spinal cord injuryS E Wickham, C S Hanson, O Shechtman, et al.
Family Practice|December 1, 1994
The effect of patients' attendance rate on the consultation in a health centre in Saudi ArabiaE A al-Faris, M A al-Dayel, C Ashton
Journal of Animal Science|March 1, 1976
Relation of high temperature regimes to energy metabolism, body composition and feed and water intake in ratsW S Alhassan, J G Buchanan-Smith, G C Ashton
Neuroscience Letters|April 12, 2014
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in ratsJ R Rivers-Auty, P F Smith, J C Ashton
Neuroreport|December 21, 2011
Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemiaJack R Rivers, Simran D S Maggo, John C Ashton
CNS & Neurological Disorders Drug Targets|January 19, 2022
The Current Evidence for the Therapeutic Role of Curcumin in Alzheimer's DiseaseAbigail R Bland, John C Ashton, Mohammad Amjad Kamal, et al.
Cerebellum (London, England)|February 3, 2005
Immunohistochemical localization of cannabinoid CB1 receptor in inhibitory interneurons in the cerebellumJohn C Ashton, Ian Appleton, Cynthia L Darlington, et al.
Pageof 25